STOXX 600Health Care· Germany

SRES

Status-Quo-Player

Sartorius Stedim Biotech

$186.70

-1.06%

Open $186.00·Prev $188.70

Delayed

STATUS-QUO-PLAYER

Power Core

The Power Core is regulatory validation lock-in: once a biologic drug is approved on a Sartorius Stedim consumable specification, switching that consumable out triggers a regulatory change control filing with re-validation risk.

Published20 Apr 2026

UniverseSTOXX 600

SectorHealth Care

↑

Direction of Movement

lateral

ROC 200

-11.2%

Financials